Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DPP4 in diabetes
Diana Röhrborn
Frontiers in Immunology (2015) Vol. 6
Open Access | Times Cited: 387

Showing 1-25 of 387 citing articles:

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 433
Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
Christian Klemann, Leona Wagner, Michael Stephan, et al.
Clinical & Experimental Immunology (2016) Vol. 185, Iss. 1, pp. 1-21
Open Access | Times Cited: 383
Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Jan‐Bernd Funcke, Philipp E. Scherer
Journal of Lipid Research (2019) Vol. 60, Iss. 10, pp. 1648-1697
Open Access | Times Cited: 259
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Jun Ren, Ne N. Wu, Shuyi Wang, et al.
Physiological Reviews (2021) Vol. 101, Iss. 4, pp. 1745-1807
Open Access | Times Cited: 251
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 173
The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect
Konstantinos Makrilakis
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 15, pp. 2720-2720
Open Access | Times Cited: 155
Autoimmune pre-disease
Katja Bieber, Jennifer E. Hundt, Xinhua Yu, et al.
Autoimmunity Reviews (2022) Vol. 22, Iss. 2, pp. 103236-103236
Closed Access | Times Cited: 77
DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature
Kunika Saini, Smriti Sharma, Yousuf Aziz Khan
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 63
Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
Ewelina Młynarska, Witold Czarnik, Natasza Dzieża, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1094-1094
Open Access | Times Cited: 4
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Christian Baumeier, Luisa Schlüter, Sophie Saussenthaler, et al.
Molecular Metabolism (2017) Vol. 6, Iss. 10, pp. 1254-1263
Open Access | Times Cited: 131
Blood-Brain Barriers in Obesity
Elizabeth M. Rhea, Therese S. Salameh, Aric F. Logsdon, et al.
The AAPS Journal (2017) Vol. 19, Iss. 4, pp. 921-930
Open Access | Times Cited: 116
Herbal medicine in the treatment of patients with type 2 diabetes mellitus
Guoming Pang, Fangxu Li, Yong Yan, et al.
Chinese Medical Journal (2019) Vol. 132, Iss. 1, pp. 78-85
Open Access | Times Cited: 99
Diabetes, hypertension, and chronic kidney disease progression: role of DPP4
Ravi Nistala, Virginia J. Savin
AJP Renal Physiology (2017) Vol. 312, Iss. 4, pp. F661-F670
Closed Access | Times Cited: 97
Soybean- and Lupin-Derived Peptides Inhibit DPP-IV Activity on In Situ Human Intestinal Caco-2 Cells and Ex Vivo Human Serum
Carmen Lammi, Carlotta Bollati, Simonetta Ferruzza, et al.
Nutrients (2018) Vol. 10, Iss. 8, pp. 1082-1082
Open Access | Times Cited: 95
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
Inés Valencia, Concepción Peiró, Óscar Lorenzo, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 95
Dietary plant flavonoids in prevention of obesity and diabetes
Biswanath Dinda, Manikarna Dinda, Arup Roy, et al.
Advances in protein chemistry and structural biology (2019), pp. 159-235
Closed Access | Times Cited: 93
Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets
Jianhua He, Lixia Chen, Hua Li
Fitoterapia (2019) Vol. 134, pp. 270-289
Closed Access | Times Cited: 89
Lecithin nano-liposomal particle as a CRISPR/Cas9 complex delivery system for treating type 2 diabetes
Eun Yi Cho, Jee‐Yeon Ryu, Han A. Reum Lee, et al.
Journal of Nanobiotechnology (2019) Vol. 17, Iss. 1
Open Access | Times Cited: 88
Multifunctional bioactive peptides derived from quinoa protein hydrolysates: Inhibition of α-glucosidase, dipeptidyl peptidase-IV and angiotensin I converting enzymes
Priti Mudgil, Bhanu Priya Kilari, Hina Kamal, et al.
Journal of Cereal Science (2020) Vol. 96, pp. 103130-103130
Closed Access | Times Cited: 71
Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
Saikat Sen, Raja Chakraborty, Pratap Kalita, et al.
World Journal of Clinical Cases (2021) Vol. 9, Iss. 28, pp. 8327-8339
Open Access | Times Cited: 64
Preparation and identification of dipeptidyl peptidase IV inhibitory peptides from quinoa protein
Haixi You, Tianliang Wu, Wei Wang, et al.
Food Research International (2022) Vol. 156, pp. 111176-111176
Closed Access | Times Cited: 51
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 49
SARS-CoV-2 cell entry beyond the ACE2 receptor
Shamila D. Alipoor, Mehdi Mirsaeidi
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10715-10727
Open Access | Times Cited: 48
Phytochemicals from Amberboa ramosa as potential DPP-IV inhibitors for the management of Type-II diabetes mellitus: Inferences from in-silico investigations
Rakesh Kumar Paul, Iqrar Ahmad, Harun Patel, et al.
Journal of Molecular Structure (2022) Vol. 1271, pp. 134045-134045
Closed Access | Times Cited: 45
Computer-Aided Screening of Phytoconstituents from Ocimum tenuiflorum against Diabetes Mellitus Targeting DPP4 Inhibition: A Combination of Molecular Docking, Molecular Dynamics, and Pharmacokinetics Approaches
Harshit Sajal, Shashank M. Patil, Ranjith Raj, et al.
Molecules (2022) Vol. 27, Iss. 16, pp. 5133-5133
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top